Komoróczy, B.; Váncsa, S.; Váradi, A.; Hegyi, P.; Vágási, V.; Baradács, I.; Szabó, A.; Nyirády, P.; Benkő, Z.; Ács, N.
Optimal Aspirin Dosage for the Prevention of Preeclampsia and Other Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2025, 14, 2134.
https://doi.org/10.3390/jcm14072134
AMA Style
Komoróczy B, Váncsa S, Váradi A, Hegyi P, Vágási V, Baradács I, Szabó A, Nyirády P, Benkő Z, Ács N.
Optimal Aspirin Dosage for the Prevention of Preeclampsia and Other Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine. 2025; 14(7):2134.
https://doi.org/10.3390/jcm14072134
Chicago/Turabian Style
Komoróczy, Balázs, Szilárd Váncsa, Alex Váradi, Péter Hegyi, Veronika Vágási, István Baradács, Anett Szabó, Péter Nyirády, Zsófia Benkő, and Nándor Ács.
2025. "Optimal Aspirin Dosage for the Prevention of Preeclampsia and Other Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" Journal of Clinical Medicine 14, no. 7: 2134.
https://doi.org/10.3390/jcm14072134
APA Style
Komoróczy, B., Váncsa, S., Váradi, A., Hegyi, P., Vágási, V., Baradács, I., Szabó, A., Nyirády, P., Benkő, Z., & Ács, N.
(2025). Optimal Aspirin Dosage for the Prevention of Preeclampsia and Other Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine, 14(7), 2134.
https://doi.org/10.3390/jcm14072134
